Fraud, Waste and Abuse: An Update for Providers
(Ambassador Ballroom 3, Level 3)
112-000-10-101-L03-P & 112-000-10-851-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Deborah A. Sopo, R.Ph., MBA, pharmacy project and development manager, HealthPlus of Michigan, South Lyon, Mich.
At the end of this presentation, participants should be able to explain the fraud, waste and abuse training requirements for pharmacy providers in Medicare Part D, and describe what pharmacy training should address to meet the Centers for Medicare and Medicaid Services requirements. Participants should also be able to identify the penalties for violations of fraud, waste and abuse, and provide pharmacy providers with common examples of fraud, waste and abuse. (This program meets pharmacy law requirements for certified pharmacy technicians and may meet fraud, waste and abuse compliance training requirements for the Medicare Part D program.)

An Update on Methacillin-resistant Staphylococcus aureus (MRSA) for Practicing Pharmacists (LaSalle A-B, Level 5)
112-000-10-102-L01-P & 112-000-10-852-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Susan Davis, Pharm.D., clinical assistant professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.; and Greg Marks, Pharm.D., infectious diseases resident, Henry Ford Hospital, Royal Oak, Mich.
At the end of this presentation, participants should be able to review the epidemiology of MRSA in community and hospital acquired infections, discuss trends in important antimicrobial resistance patterns in Staphylococcus aureus infections and describe the preventative measures to control the spread of MRSA.

Pharmacotherapy for Obesity: Past, Present and Future (Ambassador Ballroom 2, Level 3)
112-000-10-103-L01-P & 112-000-10-803-L01-T, 1.0 contact hour
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Kathryn M. Hurren, Pharm.D., clinical assistant professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to identify indications for pharmacologic therapy in overweight and obese patients; review safety and efficacy of currently available medications for weight loss; explain the mechanism
of anti-obesity medications in the pipeline; and summarize available literature regarding anti-obesity drug candidates.

Contemporary Management of Transient Ischemic Attack: The Role of the Pharmacist (Marquette A-B, Level 5)
112-000-10-104-L01-P & 112-000-10-804-L01-T, 1.0 contact hour Knowledge-based Activity
Denise H. Rhoney, Pharm.D., FCCP, FCCM, associate professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to discuss the incidence of transient ischemic attack (TIA) in the United States population and the associated risk of subsequent ischemic stroke, and describe the pathophysiology, signs and symptoms of TIA. Participants should also be able to explain the ABCD2 score to identify patients at low, moderate and high risk for subsequent stroke, and outline treatment options for TIA based upon literature.

Antimicrobial Stewardship: Current Issues and Challenges (Marquette A-B, Level 5)
112-000-10-105-L04-P & 112-000-10-805-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Curtis D. Collins, Pharm.D., MS, BCPS, AQ-ID, clinical pharmacist, infectious diseases, University of Michigan Health System, Ypsilanti, Mich.
At the end of this presentation, participants should be able to summarize current antimicrobial stewardship guidelines and recommendations; discuss stewardship-related cost-saving opportunities; and explain unique challenges in implementing antimicrobial stewardship programs in medical settings.

Radiation Countermeasures: What’s the Buzz? (LaSalle A-B, Level 5)
112-000-10-106-L04-P & 112-000-10-806-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Gregory A. Pratt, R.Ph., emergency preparedness coordinator, Michigan Pharmacists Association, DeWitt, Mich.
At the end of this presentation, participants should be able to describe the biological effects of radiation poisoning upon an affected person; describe the possible radiation-related crisis events that could impact a community and require pharmacist participation to insure a successful response; and compare the available radiation countermeasures currently stockpiled in the state of Michigan and their role in response to a radiation crisis event.

What Do You Do with an Antiretroviral Prescription? The Impact on Medication Errors in HIV Therapy (Ambassador Ballroom 2, Level 3)
112-000-10-107-L05-P & 112-000-10-807-L05-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Jean C. Lee, Pharm.D., clinical pharmacist of HIV medicine, Saint Mary’s Health Care, Grand Rapids, Mich.
At the end of this presentation, participants should be able to review the Department of Health and Human Services HIV Guidelines; describe common areas of medication errors with antiretroviral therapy; describe the impact of medication errors for a person living with HIV/AIDS; and review and assess the significance of drug interactions with antiretrovirals.

A Case Study: Pharmacist-led Medication Therapy Management (MTM) Services in a Multispecialty Physician Group Practice Clinical Setting (Ambassador Ballroom 3, Level 3)
112-000-10-108-L04-P & 112-000-10-808-L04-P, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Application-based Activity
Sandra L. Chase, Pharm.D., clinical pharmacist, SL Chase Inc., Ada, Mich.; Erica R. Clark, Pharm.D., senior clinical pharmacy manager, Priority Health, Grand Rapids, Mich.; Karin M. Proos, Pharm.D., pharmacy director, Spectrum Health Medical Group and MMPC, Grand Rapids, Mich.
At the end of this presentation, participants should be able to explain the objectives of the project from each participant’s perspective; identify the clinical and operational processes to support the service; describe the implications of the data on the effectiveness of pharmacist-led MTM services in physician practices; and discuss the value of pharmacist-led services to patients, physicians and payers of health care.

Examining the Effect of the “G” Force: The Impact of Gen Y and Gender on Education and Learning (Ambassador Ballroom 1, Level 3)
112-000-10-150-L04-P, 2.8 contact hours
Audience: Pharmacists
Application-based Activity
Brooke Moore, BS, MA, visiting assistant professor, communication, Ferris State University, Big Rapids, Mich.; and Neil A. Patten, BA, MA, Ph.D., Ferris State University, Big Rapids, Mich.
At the end of this presentation, participants should be able to identify the four different generations; compare and contrast the generations; and identify effective methods for teaching and training Generation Y. Participants should also be able to define sexual harassment issues, legal definitions and recourse; differentiate between male and female communication patterns, as well as effects of age variables and “traditional” versus “non-traditional” backgrounds; and identify the possible impacts of sexual orientation issues, legal and ethical guidelines and best practices for both preceptors and students. Invitation only. Statements of credit will be awarded independently from the Annual Convention. Sponsored by Michigan Colleges of Pharmacy Experiential Programs (McPEP) Committee that is comprised of individuals from Ferris State University, Michigan Pharmacists Association, University of Michigan and Wayne State University.

Critical Care Pearls: A Focus on ICU Delirium, Sepsis and Sedation (Marquette A-B, Level 5)
112-000-10-109-L01-P & 112-000-10-809-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Jim M. Curtis, Pharm.D., BCPS, clinical pharmacist, trauma, neuro and burn ICU, Bronson Methodist Hospital, Portage, Mich.; Daniel J. Gerard, R.Ph., critical care pharmacist, Northern Michigan Regional Hospital, Harbor Springs, Mich.; and James T. Miller, Pharm.D., BCPS, clinical pharmacy specialist, Detroit Medical Center Sinai Grace Hospital, Detroit, Mich.
At the end of this presentation, participants should be able to identify medications that can contribute to the development of delirium; characterize the signs and symptoms of delirium; and discuss the various therapeutic options for the management of delirium. Participants should also be able to define sepsis, severe sepsis and septic shock; review guidelines for the management of severe sepsis and septic shock; and review morbidity and mortality of severe sepsis and septic shock. Additionally, participants should be able to review the indications for sedation therapy in the intensive care unit (ICU); compare and contrast drugs commonly used for sedation in the ICU; and discuss strategies to optimize sedation practices and prevent complications.

Sexually Transmitted Infections: Treatment Update (LaSalle A-B, Level 5)
112-000-10-110-L01-P & 112-000-10-810-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Rachel Chambers, Pharm.D., clinical specialist, antimicrobial stewardship, Henry Ford Hospital, Detroit, Mich.
At the end of this presentation, participants should be able to describe recent trends in sexually transmitted infections; discuss the role of expedited partner therapy in Michigan; and apply the Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines to the care of individual patients.

Priorities of Michigan Legislative Leadership and Its Effect on Pharmacy (Ambassador Ballroom 2, Level 3)
112-000-10-111-L03-P & 112-000-10-811-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Rep. Gary McDowell (D-Rudyard), Michigan House of Representatives, Lansing, Mich.; and Rep. Brian Calley (R-Portland), Michigan House of Representatives, Lansing, Mich.
At the end of this presentation, participants should be able to identify issues being considered by the Senate and House Health Policy Committees that may impact pharmacy; identify the need for pharmacists and pharmacy technicians to become involved in the legislative process; and explain the impact of the state budget upon health care programs. (This program meets pharmacy law requirements for certified pharmacy technicians.)

Pharmacogenomics: The Next Frontier in Individualized Medicine (Ambassador Ballroom 3, Level 3)
112-000-10-112-L01-P & 112-000-10-812-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
David J. Edwards, Pharm.D., professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to explain basic concepts and terminology in genetics and pharmacogenomics; identify several drugs for which the application of pharmacogenomics information may contribute to the improved efficacy and safety; and list the barriers associated with implementation of pharmacogenomic testing in the clinical setting.

Medication Safety in End of Life Care
(Marquette A-B, Level 5)
112-000-10-113-L05-P & 112-000-10-813-L05-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
John A. Mulder, M.D., Faith Hospice, Grand Rapids, Mich.
At the end of this presentation, participants should be able to define medication errors, identify potential medication errors in end-of-life care, discuss medication dosage and drug interactions as potential safety issues and describe the factors that contribute to errors during transfers between care settings. Participants should also be able to discuss organizational strategies, policies and procedures that guard against errors and list action steps to reduce the risk of medication errors in their settings.

Michigan Medicaid Update (Ambassador Ballroom 2, Level 3)
112-000-10-116-L03-P & 112-000-10-816-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Carla Patrick-Fagan, MHA, PMP, pharmacy policy specialist, Medical Services Administration/Program Policy, Michigan Department of Community Health, Lansing, Mich.
At the end of this presentation, participants should be able to discuss proposed budget changes and their impact upon pharmacy; explain how legislative changes will impact Michigan Medicaid; and discuss proposed manual or other procedural changes being introduced or anticipated. (This program meets pharmacy law requirements for certified pharmacy technicians.)

Cancer Clinical Trials: Real Options, Real Answers, Real Miracles … Right at Home, Here in Michigan (LaSalle A-B, Level 5)
112-000-10-114-L01-P & 112-000-10-814-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Patrick W. Gavin, R.Ph., chairman, patient advisory board for clinical research, Grand Rapids Clinical Oncology Program, Marne, Mich.; Joanne P. McGurn, R.Ph., clinical oncology pharmacist, Munson Medical Center, Traverse City, Mich., Connie Szczepanek, RN, BSN, director, Grand Rapids Clinical Oncology Program, Grand Rapids, Mich.
At the end of this presentation, participants should be able to describe how cancer clinical trials are becoming the new “standard of care” treatment for many types of cancer; assist pharmacists in helping their patients work with oncologists in finding appropriate cancer clinical trial opportunities close to their home; and describe the role of cancer clinical trails in advancing cancer treatment. Participants should also be able to discuss the myths and facts surrounding cancer clinical trials, and discuss a real patient story describing how a pharmacist diagnosed with stage 4 cancer and participation in a cancer clinical trial that took him into remission.

Fear of Frying – Media Relations 101 (Brule A-B, Level 5)
112-000-10-115-L04-P & 112-000-10-815-L04-T, 2.8 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Kelly Rossman-McKinney, APR, CEO, The Rossman Group, Lansing, Mich.
At the end of this presentation, participants should be able to explain how to handle a media interview and maximize every media encounter; identify crisis communications strategies; and explain the advantages and disadvantages of paid and earned media. Participants should also be able to develop and stick with key messages and list tips for capturing media attention.

Medication Therapy Management: The Patient Focus (Marquette A-B, Level 5)
112-000-10-117-L04-P & 112-000-10-817-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Cathleen M. Edick, Pharm.D., D&W Pharmacy, Leslie, Mich.; and Lisa Meny, Pharm.D., assistant professor of pharmacy practice, Ferris State University College of Pharmacy, Grand Rapids, Mich.
At the end of this presentation, participants should be able to identify the key elements necessary to prepare for a medication therapy management visit; explain the thought process and basic flow of a medication therapy management visit; and list the most important points to keep in mind when working with a patient during a medication therapy management visit.

Managers as Mentors (LaSalle A-B, Level 5)
112-000-10-118-L04-P & 112-000-10-818-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Margo S. Farber, Pharm.D., manager, drug information/use policy, Detroit Medical Center, Detroit, Mich.
At the end of this presentation, participants should be able to describe the phases of the mentor relationship; identify and discuss unique opportunities and methods for mentoring pharmacists; and discuss the “managers as mentors” role and responsibility independent of practice setting and position.

Update on Michigan Medical Marihuana Act and Evidence-based Clinical Applications in Oncology (Ambassador Ballroom 1, Level 3)
112-000-10-120-L03-P & 112-000-10-820-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Celeste A. Clarkson, compliance section manager, State of Michigan, Department of Community Health, Bureau of Health Professions, Lansing, Mich.; and Claire Saadeh, Pharm.D., associate professor of pharmacy practice, Ferris State University College of Pharmacy, DeWitt, Mich.
At the end of this presentation, participants should be able to describe the Michigan Medical Marihuana Act and General Rules; provide examples of adverse effects, drug interactions and disease interactions associated with marijuana use; and summarize the clinical use and applications of medical marijuana for cancer-related conditions. (This program meets requirements for obtaining pain management continuing education credit for pharmacists and pharmacy law requirements for certified pharmacy technicians.)

Opening Session
Better Than Facebook – Up Close and Personal
with the Gubernatorial Candidates
(Ambassador Ballrooms 2-3, Level 3)
112-000-10-121-L04-P & 112-000-10-821-L04-T, 1.0 contact hour
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Moderator: Peter Pratt, senior vice president for health and human services, Public Sector Consultants, Lansing, Mich.; Confirmed Candidates: Oakland County Sherriff Mike Bouchard, Michigan Senator Tom George, United States Congressman Pete Hoekstra, Michigan Rep. Alma Wheeler Smith and Ann Arbor businessman Rick Snyder; Tentative Candidates: Lansing Mayor Virg Bernero, and Michigan Attorney General Mike Cox
At the end of this presentation, participants should be able to discuss how the candidates will address the economic conditions in Michigan; discuss the intentions of the candidates on how they plan to improve the business climate in the state; describe the candidates views on state and national health care reform; and repeat the candidates views on the value of pharmacy and pharmacy professionals for the care of the citizens of Michigan.